[1] WANG F,PAN W,WANG H,et al.Relationship between thyroid function and ICU mortality:a prospective observation study[J].Crit Care,2012,16(1):R11.
[2] WAJNER S M,MAIA A L.New insights toward the acute non-thyroidal illness syndrome[J].Front Endocrinol (Lausanne),2012,3:8.
[3] WAJNER S M,GOEMANN I M,BUENO A L,et al.IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells[J].J Clin Invest,2011,121(5):1834-1845.
[4] BIANCO A C,KIM B W.Deiodinases:implications of the local control of thyroid hormone action[J].J Clin Invest,2006,116(10):2571-2579.
[5] BOELEN A,KWAKKEL J,THIJSSEN-TIMMER D C,et al.Simultaneous changes in central and peripheral components of the hypothalamus-pituitary-thyroid axis in lipopolysaccharide-induced acute illness in mice[J].J Endocrinol,2004,182(2):315-323.
[6] CASTRO I,QUISENBERRY L,CALVO R M,et al.Septic shock non-thyroidal illness syndrome causes hypothyroidism and conditions for reduced sensitivity to thyroid hormone[J].J Mol Endocrinol,2013,50(2):255-266.
[7] PEETERS R P,WOUTERS P J,van TOOR H,et al.Serum 3,3',5'-triiodothyronine (rT3) and 3,5,3'-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities[J].J Clin Endocrinol Metab,2005,90(8):4559-4565.
[8] de GROOT L J.Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction,and in view of current evidence,should be treated with appropriate replacement therapies[J].Critical Care Clinics,2006,22(1):57-86.
[9] CHOPRA I J.Clinical review 86:Euthyroid sick syndrome:is it a misnomer?[J].J Clin Endocrinol Metab,1997,82(2):329-334.
[10] BOELEN A,PLATVOET-TER S M,WIERSINGA W M.Association between serum interleukin-6 and serum 3,5,3'-triiodothyronine in nonthyroidal illness[J].J Clin Endocrinol Metab,1993,77(6):1695-1699.
[11] BARTALENA L,BROGIONI S,GRASSO L,et al.Relationship of the increased serum interleukin-6 concentration to changes of thyroid function in nonthyroidal illness[J].J Endocrinol Invest,1994,17(4):269-274.
[12] FRIBERG L,WERNER S,EGGERTSEN G,et al.Rapid down-regulation of thyroid hormones in acute myocardial infarction:is it cardioprotective in patients with angina?[J].Arch Intern Med,2002,162(12):1388-1394.
[13] TORPY D J,TSIGOS C,LOTSIKAS A J,et al.Acute and delayed effects of a single-dose injection of interleukin-6 on thyroid function in healthy humans[J].Metabolism,1998,47(10):1289-1293.
[14] YU J,KOENIG R J.Regulation of hepatocyte thyroxine 5'-deiodinase by T3 and nuclear receptor coactivators as a model of the sick euthyroid syndrome[J].J Biol Chem,2000,275(49):38296-38301.
[15] YU J,KOENIG R J.Induction of type 1 iodothyronine deiodinase to prevent the nonthyroidal illness syndrome in mice[J].Endocrinology,2006,147(7):3580-3585.
[16] BASKOL G,ATMACA H,TANRIVERDI F,et al.Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment[J].Exp Clin Endocrinol Diabetes,2007,115(8):522-526.
[17] TORUN A N,KULAKSIZOGLU S,KULAKSIZOGLU M,et al.Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism[J].Clin Endocrinol (Oxf),2009,70(3):469-474.
[18] SANTI A,DUARTE M M,MORESCO R N,et al.Association between thyroid hormones,lipids and oxidative stress biomarkers in overt hypothyroidism[J].Clin Chem Lab Med,2010,48(11):1635-1639.
[19] O'MARA B A,DITTRICH W,LAUTERIO T J,et al.Pretranslational regulation of type I 5'-deiodinase by thyroid hormones and in fasted and diabetic rats[J].Endocrinology,1993,133(4):1715-1723.
[20] DEBAVEYE Y,ELLGER B,MEBIS L,et al.Regulation of tissue iodothyronine deiodinase activity in a model of prolonged critical illness[J].Thyroid,2008,18(5):551-560.
[21] ST G D,GALTON V A,HERNANDEZ A.Minireview:Defining the roles of the iodothyronine deiodinases:current concepts and challenges[J].Endocrinology,2009,150(3):1097-1107.
[22] BOELEN A,KWAKKEL J,WIELAND C W,et al.Impaired bacterial clearance in type 3 deiodinase-deficient mice infected with Streptococcus pneumoniae[J].Endocrinology,2009,150(4):1984-1990.
[23] KWAKKEL J,CHASSANDE O,van BEEREN H C,et al.Lacking thyroid hormone receptor beta gene does not influence alterations in peripheral thyroid hormone metabolism during acute illness[J].J Endocrinol,2008,197(1):151-158.
[24] FLIERS E,KALSBEEK A,BOELEN A.Mechanisms in endocrinology:beyond the fixed setpoint of the hypothalamus-pituitary-thyroid axis[J].Eur J Endocrinol,2014,171(5):R197-R208.
[25] KALSBEEK A,FLIERS E.Daily regulation of hormone profiles[J].Handb Exp Pharmacol,2013(217):185-226.
[26] FLIERS E,ALKEMADE A,WIERSINGA W M.The hypothalamic-pituitary-thyroid axis in critical illness[J].Best Pract Res Clin Endocrinol Metab,2001,15(4):453-464.
[27] FLIERS E,ALKEMADE A,WIERSINGA W M,et al.Hypothalamic thyroid hormone feedback in health and disease[J].Prog Brain Res,2006,153:189-207.
[28] van den BERGHE G,de ZEGHER F,BOUILLON R.Clinical review 95:Acute and prolonged critical illness as different neuroendocrine paradigms[J].J Clin Endocrinol Metab,1998,83(6):1827-1834.
[29] DEBAVEYE Y,ELLGER B,MEBIS L,et al.Tissue deiodinase activity during prolonged critical illness:effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone-releasing peptide-2[J].Endocrinology,2005,146(12):5604-5611.
[30] FREITAS B C,GEREBEN B,CASTILLO M,et al.Paracrine signaling by glial cell-derived triiodothyronine activates neuronal gene expression in the rodent brain and human cells[J].J Clin Invest,2010,120(6):2206-2217.
[31] FEKETE C,GEREBEN B,DOLESCHALL M,et al.Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus:implications for the nonthyroidal illness syndrome[J].Endocrinology,2004,145(4):1649-1655.
[32] BOELEN A,KWAKKEL J,WIERSINGA W M,et al.Chronic local inflammation in mice results in decreased TRH and type 3 deiodinase mRNA expression in the hypothalamic paraventricular nucleus independently of diminished food intake[J].J Endocrinol,2006,191(3):707-714.
[33] ZEOLD A,DOLESCHALL M,HAFFNER M C,et al.Characterization of the nuclear factor-kappa B responsiveness of the human dio2 gene[J].Endocrinology,2006,147(9):4419-4429.
[34] de VRIES E M,KWAKKEL J,EGGELS L,et al.NFkappaB signaling is essential for the lipopolysaccharide-induced increase of type 2 deiodinase in tanycytes[J].Endocrinology,2014,155(5):2000-2008.
[35] SANCHEZ E,SINGRU P S,WITTMANN G,et al.Contribution of TNF-alpha and nuclear factor-kappaB signaling to type 2 iodothyronine deiodinase activation in the mediobasal hypothalamus after lipopolysaccharide administration[J].Endocrinology,2010,151(8):3827-3835.
[36] MEBIS L,DEBAVEYE Y,ELLGER B,et al.Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illness[J].Crit Care,2009,13(5):R147.
[37] AREM R,WIENER G J,KAPLAN S G,et al.Reduced tissue thyroid hormone levels in fatal illness[J].Metabolism,1993,42(9):1102-1108.
[38] ALKEMADE A,FRIESEMA E C,KUIPER G G,et al.Novel neuroanatomical pathways for thyroid hormone action in the human anterior pituitary[J].Eur J Endocrinol,2006,154(3):491-500.
[39] SCHNEIDER M J,FIERING S N,PALLUD S E,et al.Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4[J].Mol Endocrinol,2001,15(12):2137-2148.
[40] BAUR A,BAUER K,JARRY H,et al.Effects of proinflammatory cytokines on anterior pituitary 5'-deiodinase type I and type Ⅱ[J].J Endocrinol,2000,167(3):505-515.
[41] BOELEN A,KWAKKEL J,PLATVOET-TER S M,et al.Contribution of interleukin-12 to the pathogenesis of non-thyroidal illness[J].Horm Metab Res,2004,36(2):101-106.
[42] BOELEN A,KWAKKEL J,PLATVOET-TER S M,et al.Interleukin-18,a proinflammatory cytokine,contributes to the pathogenesis of non-thyroidal illness mainly via the central part of the hypothalamus-pituitary-thyroid axis[J].Eur J Endocrinol,2004,151(4):497-502.
[43] FEKETE C,LECHAN R M.Negative feedback regulation of hypophysiotropic thyrotropin-releasing hormone (TRH) synthesizing neurons:role of neuronal afferents and type 2 deiodinase[J].Front Neuroendocrinol,2007,28(2-3):97-114.
[44] JIRASAKULDECH B,SCHUSSLER G C,YAP M G,et al.A characteristic serpin cleavage product of thyroxine-binding globulin appears in sepsis sera[J].J Clin Endocrinol Metab,2000,85(11):3996-3999.
[45] HAN G,REN J,LIU S,et al.Nonthyroidal illness syndrome in enterocutaneous fistulas[J].Am J Surg,2013,206(3):386-392.
[46] MEBIS L,LANGOUCHE L,VISSER T J,et al.The type Ⅱ iodothyronine deiodinase is up-regulated in skeletal muscle during prolonged critical illness[J].J Clin Endocrinol Metab,2007,92(8):3330-3333.
[47] MEBIS L,PALETTA D,DEBAVEYE Y,et al.Expression of thyroid hormone transporters during critical illness[J].Eur J Endocrinol,2009,161(2):243-250.
[48] CASTRO I,QUISENBERRY L,CALVO R M,et al.Septic shock non-thyroidal illness syndrome causes hypothyroidism and conditions for reduced sensitivity to thyroid hormone[J].J Mol Endocrinol,2013,50(2):255-266.
[49] WITTMANN G,SZABON J,MOHÁCSIK P,et al.Parallel regulation of thyroid hormone transporters OATP1c1 and MCT8 during and after endotoxemia at the blood-brain barrier of male rodents[J].Endocrinology,2015,156(4):1552-1564. |
